Bio-Thera Solutions, Ltd. (SHA:688177)
China flag China · Delayed Price · Currency is CNY
17.11
+0.03 (0.18%)
At close: Jul 31, 2026

Bio-Thera Solutions Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
247.8218.61289.8163.99165.94847.47
Trading Asset Securities
--90.22331.03629.89602.83
Cash & Short-Term Investments
247.8218.61380.02495.01795.831,450
Cash Growth
-50.32%-42.47%-23.23%-37.80%-45.13%17.03%
Accounts Receivable
175.05164.7108.26148.7289.75103.32
Other Receivables
2.72.994.232.091.963.67
Receivables
177.74167.68112.5150.891.72106.99
Inventory
361.98312.42253.1231.23161.990.1
Other Current Assets
181.5259.84142.34133.36112.81123.08
Total Current Assets
969.02958.56887.951,0101,1621,770
Property, Plant & Equipment
1,0981,0711,0661,014693.91579.43
Long-Term Investments
15.7615.5515.710-21.1
Other Intangible Assets
280.64218.44224.1230.38234.18239.47
Long-Term Deferred Charges
3.573.683.52.01--
Other Long-Term Assets
17.8720.568.0919.8689.397.31
Total Assets
2,3852,2872,2062,2872,1802,618

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
245.17198.69199.49171.4583.7712.73
Accrued Expenses
78.57118.8188.5369.5167.4190.91
Short-Term Debt
95.2680.0888.75105.40.0130.05
Current Portion of Long-Term Debt
201.55231.69169.450.21--
Current Portion of Leases
-0.06-3.183.492.38
Current Income Taxes Payable
1.03---0-
Current Unearned Revenue
772.75731.82545.33318.5374.08381.61
Other Current Liabilities
59.356.214.237.179.748.36
Total Current Liabilities
1,4541,3671,096725.42538.5526.04
Long-Term Debt
484.56374.21370.43323.843-
Long-Term Leases
----3.01-
Long-Term Unearned Revenue
23.7424.9231.2925.1327.974.23
Other Long-Term Liabilities
199144.81----
Total Liabilities
2,1611,9111,4971,074572.48530.27

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
414.08414.08414.08414.08414.08414.08
Additional Paid-In Capital
3,0543,0543,0543,0543,0543,054
Retained Earnings
-3,244-3,092-2,766-2,256-1,861-1,381
Comprehensive Income & Other
-0.21-0.145.6800.01-0.13
Shareholders' Equity
224.12376.03708.091,2131,6072,088
Total Liabilities & Equity
2,3852,2872,2062,2872,1802,618

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
781.37686.04628.58482.629.5132.43
Net Cash (Debt)
-533.57-467.43-248.5612.39786.331,418
Net Cash Growth
----98.42%-44.54%14.41%
Net Cash Per Share
-1.28-1.13-0.600.031.903.46
Filing Date Shares Outstanding
414.08414.08414.08414.08414.08414.08
Total Common Shares Outstanding
414.08414.08414.08414.08414.08414.08
Working Capital
-484.66-408.8-207.78284.98623.761,244
Book Value Per Share
0.540.911.712.933.885.04
Tangible Book Value
-56.52157.59483.99982.341,3731,848
Tangible Book Value Per Share
-0.140.381.172.373.324.46
Buildings
-667.49291.95291.16281.63220.84
Machinery
-913.06663.05608.15569.52507.47
Construction In Progress
-47.24580.96505.21155.8395.04